Tags
The results, though not conclusive, provide the first evidence that targeting a protein known as PCSK9 could reduce cardiovascular risks for millions of patients.
from NYT > Business Day http://ift.tt/1uhMoxy
via IFTTThttp://ift.tt/1uhMlC2 http://ift.tt/IP98QF